Literature DB >> 29531904

Tumor heterogenicity: multiple needle biopsies from different lesion sites-key to successful targeted therapy and immunotherapy.

Paul Zarogoulidis1, Vasilis Papadopoulos2, Elena Maragouli2, George Papatsibas2, Ilias Karapantzos3, Chong Bai4, Haidong Huang4.   

Abstract

Year:  2018        PMID： 29531904      PMCID： PMC5835620          DOI： 10.21037/tlcr.2018.01.07

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  20 in total

1.  Feasibility and Safety of Intrathoracic Biopsy and Repeat Biopsy for Evaluation of Programmed Cell Death Ligand-1 Expression for Immunotherapy in Non-Small Cell Lung Cancer.

Authors:  Emily B Tsai; Kelsey Pomykala; Kathleen Ruchalski; Scott Genshaft; Fereidoun Abtin; Antonio Gutierrez; Hyun J Kim; Alice Li; Carlos Adame; Ashkan Jalalian; Brian Wolf; Edward B Garon; Jonathan W Goldman; Robert Suh
Journal:  Radiology       Date:  2017-12-12       Impact factor: 11.105

Review 2.  Pharmacogenomic biomarkers for personalized cancer treatment.

Authors:  C Rodríguez-Antona; M Taron
Journal:  J Intern Med       Date:  2015-02       Impact factor: 8.989

Review 3.  Blood-based biomarkers in lung cancer: prognosis and treatment decisions.

Authors:  Meng Xu-Welliver; David P Carbone
Journal:  Transl Lung Cancer Res       Date:  2017-12

4.  Efficient utilization of EBUS-TBNA samples for both diagnosis and molecular analyses.

Authors:  F Oezkan; Am Khan; P Zarogoulidis; W Hohenforst-Schmidt; D Theegarten; K Yasufuku; T Nakajima; L Freitag; K Darwiche
Journal:  Onco Targets Ther       Date:  2014-11-10       Impact factor: 4.147

5.  Radial Endobronchial Ultrasound (EBUS) Guided Suction Catheter-Biopsy in Histological Diagnosis of Peripheral Pulmonary Lesions.

Authors:  Bojan Zaric; Vladimir Stojsic; Vladimir Carapic; Tomi Kovacevic; Goran Stojanovic; Milana Panjkovic; Ioannis Kioumis; Kaid Darwiche; Konstantinos Zarogoulidis; Grigoris Stratakos; Drosos Tsavlis; Wolfgang Hohenforst-Schmidt; Georgia Pitsiou; Athanasios Zissimopoulos; Nikos Sachpekidis; Ilias Karapantzos; Chrysanthi Karapantzou; Paul Zarogoulidis; Branislav Perin
Journal:  J Cancer       Date:  2016-01-01       Impact factor: 4.207

6.  Immunotherapy "Shock" a case series of PD-L1 100% and pembrolizumab first-line treatment.

Authors:  Paul Zarogoulidis; Evaggelia Athanasiou; Theodora Tsiouda; Dimitrios Hatzibougias; Haidong Huang; Chong Bai; Georgia Trakada; Lemonia Veletza; Anastasios Kallianos; Christoforos Kosmidis; Nikolaos Barbetakis; Dimitrios Paliouras; Aggeliki Rapti; Dimitrios Drougas; Wolfgang Hohenforst-Schmidt
Journal:  Respir Med Case Rep       Date:  2017-08-29

7.  Effectiveness of the Benign and Malignant Diagnosis of Mediastinal and Hilar Lymph Nodes by Endobronchial Ultrasound Elastography.

Authors:  Haidong Huang; Zhiang Huang; Qin Wang; Xinan Wang; Yuchao Dong; Wei Zhang; Paul Zarogoulidis; Yan-Gao Man; Wolfgang Hohenforst Schmidt; Chong Bai
Journal:  J Cancer       Date:  2017-07-02       Impact factor: 4.207

8.  Protein signatures of molecular pathways in non-small cell lung carcinoma (NSCLC): comparison of glycoproteomics and global proteomics.

Authors:  Shuang Yang; Lijun Chen; Daniel W Chan; Qing Kay Li; Hui Zhang
Journal:  Clin Proteomics       Date:  2017-08-15       Impact factor: 3.988

9.  Re-biopsy after relapse of targeted therapy. T790M after epidermal growth factor mutation, where and why based on a case series.

Authors:  Paul Zarogoulidis; Aggeliki Rapti; Chrysanthi Sardeli; Panagiotis Chinelis; Anastasia Athanasiadou; Katerina Paraskevaidou; Anastasios Kallianos; Lemonia Veletza; Georgia Trakada; Wolfgang Hohenforst-Schmidt; Haidong Huang
Journal:  Respir Med Case Rep       Date:  2017-05-30

10.  Multiple guided technologies based on radial probe endobronchial ultrasound for the diagnosis of solitary peripheral pulmonary lesions: a single-center study.

Authors:  Huang Haidong; Ning Yunye; Zhang Wei; Paul Zarogoulidis; Wolfgang Hohenforst-Schmidt; Yan-Gao Man; Yang Yuguang; Dong Yuchao; Bai Chong
Journal:  J Cancer       Date:  2017-09-29       Impact factor: 4.207
View more
  3 in total

1.  EBUS-TNBA 22G samples: Comparison of PD-L1 expression between DAKO and BIOCARE®.

Authors:  Konstantinos Sapalidis; Paul Zarogoulidis; Dimitris Petridis; Christoforos Kosmidis; Barbara Fyntanidou; Kosmas Tsakiridis; Elena Maragouli; Aikaterini Amaniti; Dimitris Giannakidis; Charilaos Koulouris; Stylianos Mantalobas; Athanasios Katsaounis; Vyron Alexandrou; Georgios Koimtzis; Efstathios Pavlidis; Anastasios Barmpas; Theodora Tsiouda; Chrysanthi Sardeli; Zoi Aidoni; Haidong Huang; Qiang Li; Wolfgang Hohenforst-Schmidt; Isaak Kesisoglou
Journal:  J Cancer       Date:  2019-08-20       Impact factor: 4.207

Review 2.  The Role of Intratumor Heterogeneity in the Response of Metastatic Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors.

Authors:  Marcin Nicoś; Paweł Krawczyk; Nicola Crosetto; Janusz Milanowski
Journal:  Front Oncol       Date:  2020-12-04       Impact factor: 6.244

3.  Cryo-Biopsy versus 19G needle versus 22G needle with EBUS-TBNA endoscopy.

Authors:  Rena Oikonomidou; Dimitris Petridis; Christoforos Kosmidis; Konstantinos Sapalidis; Wolfgang Hohenforst-Schmidt; Vagelis Christakidis; Savas Petanidis; Dimitris Mathaios; Eleni Isidora Perdikouri; Sofia Baka; Christos Tolis; Anastasios Vagionas; Bojan Zaric; Aris Ioannidis; Marios Anemoulis; Konstantinos Porpodis; Vasileios Papadopoulos; Paul Zarogoulidis
Journal:  J Cancer       Date:  2022-08-08       Impact factor: 4.478
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.